Abcellera Biologics Inc
NASDAQ:ABCL
Income Statement
Earnings Waterfall
Abcellera Biologics Inc
Revenue
|
38m
USD
|
Operating Expenses
|
-275.2m
USD
|
Operating Income
|
-237.2m
USD
|
Other Expenses
|
90.8m
USD
|
Net Income
|
-146.4m
USD
|
Income Statement
Abcellera Biologics Inc
Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||
Revenue |
422
N/A
|
438
+4%
|
444
+1%
|
375
-15%
|
489
+30%
|
507
+4%
|
603
+19%
|
485
-20%
|
181
-63%
|
145
-20%
|
50
-65%
|
38
-25%
|
|
Operating Income | |||||||||||||
Operating Expenses |
(104)
|
(127)
|
(160)
|
(171)
|
(218)
|
(237)
|
(267)
|
(269)
|
(254)
|
(261)
|
(259)
|
(275)
|
|
Selling, General & Administrative |
(19)
|
(30)
|
(42)
|
(49)
|
(56)
|
(61)
|
(66)
|
(67)
|
(69)
|
(71)
|
(72)
|
(75)
|
|
Research & Development |
(30)
|
(36)
|
(54)
|
(62)
|
(76)
|
(88)
|
(97)
|
(108)
|
(134)
|
(144)
|
(155)
|
(176)
|
|
Depreciation & Amortization |
(5)
|
(8)
|
(11)
|
(15)
|
(15)
|
(17)
|
(18)
|
(28)
|
(29)
|
(30)
|
(31)
|
(24)
|
|
Other Operating Expenses |
(50)
|
(53)
|
(53)
|
(46)
|
(70)
|
(72)
|
(87)
|
(66)
|
(22)
|
(17)
|
(2)
|
0
|
|
Operating Income |
318
N/A
|
312
-2%
|
284
-9%
|
204
-28%
|
272
+33%
|
270
-1%
|
336
+24%
|
217
-36%
|
(73)
N/A
|
(116)
-59%
|
(209)
-80%
|
(237)
-13%
|
|
Pre-Tax Income | |||||||||||||
Interest Income Expense |
(4)
|
(2)
|
0
|
(3)
|
(0)
|
0
|
0
|
12
|
22
|
33
|
43
|
46
|
|
Total Other Income |
10
|
6
|
7
|
18
|
18
|
15
|
21
|
11
|
12
|
13
|
9
|
17
|
|
Pre-Tax Income |
324
N/A
|
315
-3%
|
290
-8%
|
219
-25%
|
288
+32%
|
284
-2%
|
355
+25%
|
239
-33%
|
(40)
N/A
|
(71)
-78%
|
(157)
-121%
|
(174)
-11%
|
|
Net Income | |||||||||||||
Tax Provision |
(83)
|
(84)
|
(80)
|
(66)
|
(84)
|
(83)
|
(107)
|
(81)
|
(10)
|
(3)
|
28
|
28
|
|
Income from Continuing Operations |
241
|
232
|
211
|
154
|
205
|
200
|
248
|
159
|
(50)
|
(74)
|
(129)
|
(146)
|
|
Net Income (Common) |
241
N/A
|
232
-4%
|
211
-9%
|
154
-27%
|
205
+33%
|
200
-2%
|
248
+24%
|
159
-36%
|
(50)
N/A
|
(74)
-47%
|
(129)
-75%
|
(146)
-13%
|
|
EPS (Diluted) |
0.75
N/A
|
0.85
+13%
|
0.75
-12%
|
0.48
-36%
|
0.65
+35%
|
0.7
+8%
|
0.8
+14%
|
0.5
-38%
|
-0.18
N/A
|
-0.27
-50%
|
-0.45
-67%
|
-0.51
-13%
|